Bone Biologics (BBLG) Times Interest Earned (2014 - 2021)
Bone Biologics (BBLG) reported Times Interest Earned of -$31.21 for Q4 2021, down 3638.38% year-over-year from $0.88 in Q4 2020, and down 3696.19% quarter-over-quarter from -$0.82 in Q3 2021.
Bone Biologics (BBLG) Times Interest Earned (2014 - 2021) Analysis & Trends
Bone Biologics (BBLG) has 8 years of Times Interest Earned data on file, last reported at -$31.21 in Q4 2021.
- Times Interest Earned for Q4 2021 came in at -$31.21, down 3638.38% year-over-year; the trailing twelve-month figure through Sep 2022 was -$192.38 (down 23411.59% YoY), and the FY2021 annual result was -$1.37, down 65.75% from the prior year.
- Times Interest Earned eased to -$31.21 in Q4 2021 per BBLG's latest filing, from -$0.82 in the prior quarter.
- Over five years, Times Interest Earned peaked at $2.06 in Q2 2017 and troughed at -$31.21 in Q4 2021.
- A 5-year average of -$2.94 and a median of -$1.0 in 2017 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2018 and 2021: Times Interest Earned jumped 287.07% in 2018, then tumbled 3638.38% in 2021.
- A 5-year view of Times Interest Earned shows it stood at -$0.9 in 2017, then plunged by 495.04% to -$5.35 in 2018, then surged by 79.52% to -$1.09 in 2019, then grew by 23.76% to -$0.83 in 2020, then plunged by 3638.38% to -$31.21 in 2021.
- Business Quant data shows BBLG's Times Interest Earned at -$31.21 in Q4 2021, -$0.82 in Q3 2021, and -$0.89 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -31.21 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -0.89 |
| Mar 31, 2021 | -0.72 |
| Dec 31, 2020 | -0.83 |
| Sep 30, 2020 | -0.59 |
| Jun 30, 2020 | -0.54 |
| Mar 31, 2020 | -1.33 |
| Dec 31, 2019 | -1.09 |
| Sep 30, 2019 | -1.16 |
| Jun 30, 2019 | -2.78 |
| Mar 31, 2019 | -5.47 |
| Dec 31, 2018 | -5.35 |
| Sep 30, 2018 | 1.70 |
| Jun 30, 2018 | -2.14 |
| Mar 31, 2018 | -3.06 |
| Dec 31, 2017 | -0.90 |
| Sep 30, 2017 | -0.91 |
| Jun 30, 2017 | 2.06 |
| Mar 31, 2017 | -2.83 |